Year-end Sale % OFF 
Abstract
AbstractAdapting MRI to the field of molecular imaging is a challenge that continues to attract considerable attention. The detection of a given biomolecular analyte requires the availability of a molecular probe that is able to respond with a sufficient signal gap in order to overcome the low sensitivity of MRI. To this end, 19F MRI has yielded promising results due to its negligible endogenous background signals. Several small molecular probes have been reported; however, the low sensitivity of 19F MRI render the detection of biomarkers in vivo difficult, in view of their sub‐nanomolar concentration on site. Researchers have thus directed their attention toward larger chemical objects containing large numbers of 19F nuclei as smart platforms that allow a stimuli‐induced response. This article discusses the recent advances and future directions in the design of nano‐probes that respond to chemical or physical stimuli recognized as biomarkers for life and disease.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
